Scaling Medical Bioprocessing Supplier

“Excellent bespoke brokerage catered to the utmost of your financial position and needs… Their access to financial markets and knowledge of business needs versus business position to manage realistic loan products were very well positioned and tailored. Highly recommended.”

We are proud to have represented Alan from the early stages in realising his aspirations and objective, from leaving employment to establishing a local biotech and pharmaceutical distribution organisation suppling pharmaceuticals worldwide. Despite strong early traction with customer interest and distributor discussions, the business was less than six months into trading with lenders and brokers unable to assist, RBFs principles of founded by business owners for business owners we were able to lend our expertise not only short term, but long term allowing the business to thrive….

To scale operations and capitalise on growing demand, Alan required funding to:

Like many new biotech businesses, Alan faced hurdles that traditional lenders struggle to support:

With less than six months of trading, mainstream lenders were reluctant to provide support, despite clear market demand.

Without an established financial track record, demonstrating affordability to conventional lenders proved difficult.

Suppliers often require upfront payment for imported stock, while customers operate on lengthy credit terms both nationally and internationally. This created a significant cash flow gap between placing orders and receiving payments.

Finding not just a short-term fix, but a sustainable funding partnership to support accelerated growth.

 “The main challenge was cash flow: suppliers often require upfront payments, while customers operate on lengthy credit terms, creating a gap between orders and payments.”

RB Finance worked closely with Alan to structure a comprehensive funding solution that addressed both immediate needs and long-term growth:

By demonstrating strong market traction through early customer interest, distribution discussions, and sales representative agreements, our team was able to structure a compelling loan case that secured funding where traditional routes had failed.

The tailored funding solution enabled Alan’s biotech business to:

The funding has allowed the business to scale operations efficiently, avoiding the growth restrictions that often hold back early-stage companies in the biotech sector.

“Mark and his team understand the unique challenges facing biotech businesses. Their ability to structure funding for companies with short trading histories, while building a long-term partnership for future growth, made all the difference in scaling our operations.”